NEW YORK, NY– – Despite disappointing third quarter results for some of biotechnology’s up-and-coming stars, there is plenty of optimism in the industry. According to Lipper Inc. healthcare and biotechnology …
Continued here:
Dynavax and Vical — Undervalued and Gaining Attention
